Cargando…

Semaglutide might be a key for breaking the vicious cycle of metabolically associated fatty liver disease spectrum?

Metabolically associated fatty liver disease (MAFLD) is a liver manifestation of metabolic syndrome potentially related to unfavorable hepatic and extrahepatic outcomes and progression to cirrhosis. Up to date, there are no approved pharmacotherapies for the treatment of MAFLD, so management focused...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cigrovski Berkovic, Maja, Rezic, Tanja, Bilic-Curcic, Ines, Mrzljak, Anna
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Baishideng Publishing Group Inc 2022
Materias:	Opinion Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9297405/ https://www.ncbi.nlm.nih.gov/pubmed/36051145 http://dx.doi.org/10.12998/wjcc.v10.i20.6759

Ejemplares similares

What is the gut feeling telling us about physical activity in colorectal carcinogenesis?
por: Berkovic, Maja Cigrovski, et al.
Publicado: (2020)

How far along are we in revealing the connection between metformin and colorectal cancer?
por: Berkovic, Maja Cigrovski, et al.
Publicado: (2021)

Exploring new treatment options for polycystic ovary syndrome: Review of a novel antidiabetic agent SGLT2 inhibitor
por: Marinkovic-Radosevic, Jelena, et al.
Publicado: (2021)

NAFLD and Physical Exercise: Ready, Steady, Go!
por: Cigrovski Berkovic, Maja, et al.
Publicado: (2021)

Shifting perspectives – interplay between non-alcoholic fatty liver disease and insulin resistance in lean individuals
por: Bilic-Curcic, Ines, et al.
Publicado: (2021)

Prehabilitation of overweight and obese patients with dysglycemia awaiting bariatric surgery: Predicting the success of obesity treatment
por: Cigrovski Berkovic, Maja, et al.
Publicado: (2022)

Post-transplant diabetes mellitus and preexisting liver disease - a bidirectional relationship affecting treatment and management
por: Cigrovski Berkovic, Maja, et al.
Publicado: (2020)

Fear of hypoglycemia, a game changer during physical activity in type 1 diabetes mellitus patients
por: Cigrovski Berkovic, Maja, et al.
Publicado: (2021)

Semaglutide-eye-catching results
por: Cigrovski Berkovic, Maja, et al.
Publicado: (2023)

Coagulation and Endothelial Dysfunction Associated with NAFLD: Current Status and Therapeutic Implications
por: Ogresta, Doris, et al.
Publicado: (2022)

The Effects of Transition from Bedtime to Morning Glargine Administration in Patients with Poorly Regulated Type 1 Diabetes Mellitus: Croatian Pilot Study
por: Gradiser, Marina, et al.
Publicado: (2015)

Malignant insulinoma: Can we predict the long-term outcomes?
por: Cigrovski Berkovic, Maja, et al.
Publicado: (2022)

Are We Compensating for the Lack of Physical Activity in Our Diabetic Patients with Treatment Intensification?
por: Cigrovski Berkovic, Maja, et al.
Publicado: (2017)

Glucagon-like-1 receptor agonists and sodium/glucose cotransporter-2 inhibitors combination—are we exploiting their full potential in a real life setting?
por: Cigrovski Berkovic, Maja, et al.
Publicado: (2020)

Long-Term Effectiveness of Liraglutide in Association with Patients’ Baseline Characteristics in Real-Life Setting in Croatia: An Observational, Retrospective, Multicenter Study
por: Berkovic, Maja Cigrovski, et al.
Publicado: (2017)

Effect of COVID-19 on management of type 1 diabetes: Pushing the boundaries of telemedical healthcare
por: Bilic Curcic, Ines, et al.
Publicado: (2021)

Psoriasis Severity—A Risk Factor of Insulin Resistance Independent of Metabolic Syndrome
por: Polic, Melita Vuksic, et al.
Publicado: (2018)

Pestilence and famine: Continuing down the vicious cycle with COVID-19
por: Hyder, Sudipta, et al.
Publicado: (2022)

The effectiveness of lixisenatide as an add on therapy to basal insulin in diabetic type 2 patients previously treated with different insulin regimes: a multi-center observational study
por: Božek, Tomislav, et al.
Publicado: (2018)

Flash Glucose Monitoring in Croatia: The Optimal Number of Scans per Day to Achieve Good Glycemic Control in Type 1 Diabetes
por: Canecki-Varzic, Silvija, et al.
Publicado: (2023)

Assessment of FreeStyle Libre Flash Glucose Monitoring System Implementation in Real Life Clinical Setting: A Prospective Observational Study
por: Canecki Varzic, Silvija, et al.
Publicado: (2021)

Diabetes and climate change: breaking the vicious cycle
Publicado: (2023)

The prognostic role of diabetes mellitus type 2 in the setting of hepatocellular carcinoma: a systematic review and meta-analysis
por: Mrzljak, Anna, et al.
Publicado: (2022)

Prognostic role of metformin in diabetes mellitus type 2 patients with hepatocellular carcinoma: A systematic review and meta-analysis
por: Cigrovski Berkovic, Maja, et al.
Publicado: (2023)

Obesity Paradox in Chronic Liver Diseases: Product of Bias or a Real Thing?
por: Curcic, Ines Bilic, et al.
Publicado: (2019)

Friedreich's ataxia: the vicious circle hypothesis revisited
por: Bayot, Aurélien, et al.
Publicado: (2011)

Management of Glycemia during Acute Aerobic and Resistance Training in Patients with Diabetes Type 1: A Croatian Pilot Study
por: Ivandic, Marul, et al.
Publicado: (2023)

Transgenerational Transmission of Non-communicable Diseases: How to Break the Vicious Cycle?
por: Bronson, Stephen C, et al.
Publicado: (2021)

Breaking the vicious cycle between breast cancer cells and tumor-associated macrophages
por: Su, Shicheng, et al.
Publicado: (2014)

The year 2020, a milestone in breaking the vicious cycle of poverty and illness in China
por: Wang, Yun-Ping, et al.
Publicado: (2020)

Sleep disturbances and non-cyclical breast pain: where to break the vicious cycle?
por: Basım, Pelin, et al.
Publicado: (2021)

Anti‐Oxidative and Anti‐Inflammatory Micelles: Break the Dry Eye Vicious Cycle
por: Li, Su, et al.
Publicado: (2022)

Breaking the vicious cycle: The interplay between loneliness, metabolic illness, and mental health
por: Ahmed, Minhal, et al.
Publicado: (2023)

Severe congenital neutropenia and liver abscess: Surgical treatment breaks the vicious cycle
por: Lao, Jing, et al.
Publicado: (2023)

HIV and the Gut Microbiota, Partners in Crime: Breaking the Vicious Cycle to Unearth New Therapeutic Targets
por: Vyboh, Kishanda, et al.
Publicado: (2015)

Human mitochondrial transcriptional factor A breaks the mitochondria-mediated vicious cycle in Alzheimer’s disease
por: Oka, Sugako, et al.
Publicado: (2016)

Alzheimer Drug Trials: Combination of Safe and Efficacious Biologicals to Break the Amyloidosis-Neuroinflammation Vicious Cycle
por: Bartfai, Tamas, et al.
Publicado: (2020)

Vicious Cycle between Brain and Muscle
por: Chung, Beom Sun
Publicado: (2019)

The Anti-VEGF(R) Drug Discovery Legacy: Improving Attrition Rates by Breaking the Vicious Cycle of Angiogenesis in Cancer
por: Ribatti, Domenico, et al.
Publicado: (2021)

Gene Therapy Leaves a Vicious Cycle
por: Goswami, Reena, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_b7kero7m1pn544119etutvqr29